Search
for
Sort by
Research 751–780 of 1000+
- Fighting for Life: American Military Medicine in World War II
- Clinical Development of Topoisomerase-Interactive Drugs
- Doctor, Heal Thyself: Treatment Seeking for Stress and Health Researchers
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Détection précoce de la cardiotoxicité due à la doxorubicine chez le miniporc par imagerie par résonance magnétique
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice
- Covid induced telogen effluvium (CITE): An insight
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- COVID-19 and hypopituitarism
- Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Cluster Headache-Acute and Prophylactic Therapy
- Smoothened receptor inhibitor vismodegib for the treatment of basal cell carcinoma: a retrospective analysis of efficacy and side effects
- Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19
- Correlations between soluble receptor for advanced glycation end products and heme oxogenase-1 in post-COVID-19 patients with telogen effluvium
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Cephalalgic Alopecia Areata
- The immune response to COVID‐19: Does sex matter?
- Presentation and Management of Cutaneous Manifestations of COVID-19
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial